UB
BMRN icon

UMB Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

UMB Bank’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
2,226
-267
-11% -$14.6K ﹤0.01% 933
2026
Q1 		$141K Buy
2,493
+1,484
+147% +$86.5K ﹤0.01% 817
2025
Q4 		$60K Sell
1,009
-656
-39% -$35.7K ﹤0.01% 1179
2025
Q3 		$90.2K Sell
1,665
-270
-14% -$15.4K ﹤0.01% 912
2025
Q2 		$106K Sell
1,935
-312
-14% -$18.4K ﹤0.01% 804
2025
Q1 		$159K Buy
2,247
+1,228
+121% +$82.6K ﹤0.01% 622
2024
Q4 		$67K Buy
1,019
+736
+260% +$49.3K ﹤0.01% 798
2024
Q3 		$19.9K Buy
283
+138
+95% +$11.5K ﹤0.01% 1237
2024
Q2 		$11.9K Buy
145
+107
+282% +$8.91K ﹤0.01% 1229
2024
Q1 		$3.32K Hold
38
– – ﹤0.01% 1425
2023
Q4 		$3.66K Hold
38
– – ﹤0.01% 1444
2023
Q3 		$3.36K Hold
38
– – ﹤0.01% 1476
2023
Q2 		$3.29K Sell
38
-30
-44% -$2.82K ﹤0.01% 1467
2023
Q1 		$6.61K Buy
+68
New +$7.05K ﹤0.01% 1374
2022
Q4 		– Sell
-108
Closed -$9K – 1717
2022
Q3 		$9K Hold
108
– – ﹤0.01% 1332
2022
Q2 		$9K Hold
108
– – ﹤0.01% 1414
2022
Q1 		$8K Hold
108
– – ﹤0.01% 1541
2021
Q4 		$10K Buy
+108
New +$8.91K ﹤0.01% 1446

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UMB Bank's BMRN Position: Q2 2026 in Review

UMB Bank reduced its BioMarin Pharmaceuticals (BMRN) stake by 11% in Q2 2026, selling an estimated $14.6K and leaving 2,226 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

UMB Bank first reported a position in BMRN in Q4 2021 and has held it in 18 quarters since. The position peaked at $159K in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • UMB Bank held 2,226 shares of BioMarin Pharmaceuticals worth $127K as of Q2 2026.
  • UMB Bank sold 267 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #933 holding.
  • UMB Bank first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • UMB Bank's BioMarin Pharmaceuticals position peaked at $159K in Q1 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.